AbbVie (ABBV) Accumulated Expenses (2012 - 2015)

AbbVie (ABBV) has reported Accumulated Expenses for 4 consecutive years, with $632.0 million the latest figure, recorded in Q4 2015.

• In Q4 2015, Accumulated Expenses rose 1.44% year-over-year to $632.0 million; the TTM figure through Dec 2015 stood at $632.0 million (up 1.44% YoY), while the FY2015 annual figure was $632.0 million, up 1.44% from the prior year.
• Accumulated Expenses improved to $632.0 million in Q4 2015 per ABBV's latest filing, from $623.0 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $632.0 million in Q4 2015 and bottomed at $523.0 million in Q4 2012.
• Historically, Accumulated Expenses has averaged $599.8 million across 4 years, with a median of $622.0 million in 2013.
• Annual changes were most pronounced in 2013 — Accumulated Expenses increased 18.74% — and 2014, when it grew 0.32%.
• AbbVie's Accumulated Expenses stood at $523.0 million in 2012, then increased by 18.74% to $621.0 million in 2013, then increased by 0.32% to $623.0 million in 2014, then advanced by 1.44% to $632.0 million in 2015.
• Business Quant data shows ABBV's Accumulated Expenses at $632.0 million in Q4 2015, $623.0 million in Q4 2014, and $621.0 million in Q4 2013.